
Opinion|Podcasts|August 1, 2024
Optimizing Treatment Outcomes in Retinal Vein Occlusion
Listen
0:00 / 0:00
Key Takeaways
- Retinal vein occlusion requires strategic treatment selection and diagnostic approaches to address its complex challenges effectively.
- Angiopoietin-2 significantly impacts RVO progression and treatment outcomes, necessitating its consideration in management strategies.
A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.
Advertisement
0:50 RVO Challenges
2:30 Treatment Selection
8:00 Diagnostics
10:50 Role of Ang-2 in RVO
13:50 Steroids in RVO
18:00 Patient Education
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Navigating Emotional Burden in IBD
2
Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD
3
Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies
4
Why Dermatologists Should Add Serum Tryptase to the Workup for Chronic Itch
5























































































